The Human Epidermal Growth Factor Receptor 2 Screening Tests for Breast Cancer Suggested by the New Updated Recommendation of the American Society of Clinical Oncology/College of American Pathologists Will Involve a Rise of the In-Situ Hybridization Tests for the European Laboratories of Pathology

Aims. The differences between the 2007 and the 2013 ASCO/CAP HER2 guidelines have been compared. We also discussed the potential consequences in our pathological practice. Material and Methodology. 189 HER2 fluorescence in situ hybridisation (FISH) tests were performed from 1016 preliminary HER2 imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Garbar, Christian, Savoye, Aude-Marie, Mascaux, Corinne, Brabencova, Eva, Curé, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040196/
https://www.ncbi.nlm.nih.gov/pubmed/24944830
http://dx.doi.org/10.1155/2014/793695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040196/
https://www.ncbi.nlm.nih.gov/pubmed/24944830
http://dx.doi.org/10.1155/2014/793695

Ejemplares similares